Introducing

MiniMed® 530G with Enlite®

Better glucose control with the MiniMed 530G system† 1, 2

Learn More about Insulin Pump Therapy
MiniMed 530G with Enlite

Threshold Suspend Automation

The Threshold Suspend feature automatically stops insulin delivery when sensor glucose values reach a preset low threshold.


1. Most advanced diabetes management tool. Mimics some of the functions of a healthy pancreas.


2. Is only available with the MiniMed 530G system in US.

Threshold Suspend Automation

Better Protection with Enlite2

More comfortable and accurate than ever before, our new sensor gives you better protection from highs and lows2.

Learn More about Enlite Sensor
Better protection with Enlite

A Breakthrough in Better Glucose Control

As an integrated insulin pump and CGM system, the MiniMed 530G system offers better control than multiple daily injections or conventional insulin pumps. It increases confidence to achieve better control.1,2,3

A breakthrough in better glucose control

Features & Benefits

  • Threshold Suspend automatically stops insulin delivery when your sensor glucose values reach a preset low threshold giving you increased confidence for better control.
  • CGM integration provides readings every five minutes. Allowing you to identify trends and make adjustments to your lifestyle or treatment
  • Predictive alerts notify you up to 30 minutes before you reach a certain sensor glucose level. Helping you to react sooner to low and high sensor glucose levels
  • Accurate Enlite sensor features a 31% improvement in overall accuracy versus Sof-sensor® glucose sensor5,6. More reliable detection of high and low glucose levels
  • Bolus Wizard calculates an insulin bolus amount with minimal button pushes, making life easier and helping prevent calculation errors.
Threshold Suspend
CGM Integration
Predictive Alerts
Enlite Sensor
Bolus Wizard
minimed sensor

Try the MiniMed 530G System on for Size

Get Started Now >

 

References
    • * ...that is approved by the United States Food and Drug Administration. Medtronic has a similar product already approved in Europe
    • Study used previous generation SAP pumps without Threshold suspend feature versus MDI
    • 1 Bergenstal RM, Tamborlane WV, Ahmann A, et al. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med. 2010;363:311–320.
    • 2 Battelino T, Conget I, Olsen B, et al. The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomized controlled trial. Diabetologia. 2012;55:3155-3162.
    • 3 User evaluations. Data on file, Medtronic MiniMed, Inc. Northridge, CA.
    • 4 Bergenstal RM, Tamborlane WV, Ahmann A, et al. STAR 3 Study Group. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med. 2010;363(4):311–320.